BİDDER

Bilim İnsanları Dayanışma Derneği

Health News

  • Apr 25 2025 This Week in Cardiology
    AI and ECGs, novel ways to treat hypertension, combined lipid-lowering therapy after myocardial infarction, PFA and silent stroke, a move toward accountability in AF ablation, and pacing issues in TTVR are the topics John Mandrola, MD, discusses in this week's podcast. theheart.org on Medscape
  • When Benzos Fail, Ketamine Delivers
    Drs Glatter, Goodloe, Pepe, and Scheppke explore the role of ketamine as a rescue drug for patients experiencing benzodiazepine-refractory status epilepticus in the prehospital setting. Medscape Emergency Medicine
  • Are Top Cancer Centers Misleading on Screening?
    Dr Bishal Gyawali's new study reveals screening guidelines from top cancer centers often strays from gold-standard. Medscape Oncology
  • Popular Diabetes Drugs Linked to Fall Risk in T2D
    In patients with T2D who had been hospitalized for poorly controlled blood glucose, SGLT2 inhibitors nearly doubled the risk for falls, and combined use with GLP-1 RAs nearly tripled the risk. Medscape Medical News
  • Key Blood Proteins Predict MASLD Up to 16 Years in Advance
    Early identification of individuals at a high risk for MASLD could “profoundly transform” intervention strategies, experts say. Medscape Medical News
  • FDA Approves Penpulimab for Nasopharyngeal Cancer
    Penpulimab is approved for multiple indications in China, but this marks the first US approval for the novel monoclonal antibody. Medscape Medical News
RSS sorunu: A feed could not be found at `https://www.mayoclinic.org/rss/all-health-information-topics`; the status code is `200` and content-type is `text/html; charset=utf-8`
  • New cell therapy shows promising results in advanced tumor diseases
    In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as skin, lung, or bone and soft tissue cancer (sarcomas), they have not yet proven themselves as a treatment method. Tumor shrinkage was achieved […]
  • An earth-abundant mineral for sustainable spintronics
    Iron-rich hematite, commonly found in rocks and soil, turns out to have magnetic properties that make it a promising material for ultrafast next-generation computing.
  • New way to prevent duodenal cancer
    People with the hereditary disease familial adenomatous polyposis (FAP) have a greatly increased risk of developing a malignant tumor of the duodenum. Researchers have now discovered a mechanism in the local immune system that can drive the development of cancer. They see this as a promising new approach to preventing duodenal carcinoma in people with […]
  • Structure dictates effectiveness, safety in nanomedicine
    Historically, small molecule drugs have been precisely designed down to the atomic scale. Considering their relatively large complex structures, nanomedicines have lagged behind. Researchers argue this precise control should be applied to optimize new nanomedicines.
  • New body-fluid biomarker for Parkinson's disease discovered
    Researchers have discovered a new biomarker for Parkinson's disease. A misfolded protein facilitates reliable diagnosis even in the early stages of Parkinson's disease in body fluids.
  • AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate
    A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function that triggers a pathway that disrupts how cells in the brain turn genes on and off.